explore -WSS

explore

author：focus 2025-08-04 03:41:51 - browse：9143

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： CRISPR pioneers react to Casgevy, first gene

leisure time

WSS

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

'The boss' wants server deleted: New allegations emerge in Trump indictment

Poor hospice wound care hurts patients and families

Wegovy, Zepbound and weight loss drugs that preserve muscle

Interest rates are at a 22

Gain of function research would be limited under House proposal

knowledge

explore

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Congress must reauthorize a committee to support older Americans

Medicare proposal to cover medical devices draws a mixed reaction

Biden jokes that Republicans may impeach him because inflation is starting to cool down

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hospitals look to new technology to keep health care workers safe

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

After affirmative action ruling, medical educators look to 'holistic review'

Marc Tessier

entertainment

Does good food count as health care? Study aims to find out

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Anthos stroke drug appears safer than common blood thinner

Surge of respiratory disease in China has likely explanation

Ransomware attacks on hospitals: Study outlines patient impact

Surge of respiratory disease in China has likely explanation

leisure time

focus

explore

hotspot